Ryan Ungaro MD MS
Inflammatory Bowel Disease
Associate Professor, Gastroenterology
Join to view full profile
1 Gustave L Levy PlaceNew York, NY 10029
Phone+1 212-241-8100
Dr. Ungaro is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 2013 - 2016- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalChief Residency, Internal Medicine, 2012 - 2013
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2009 - 2012
- Icahn School of Medicine at Mount SinaiClass of 2009
Certifications & Licensure
NY State Medical License 2011 - 2028
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Crohn's and Colitis Foundation Career Development Award 2017
- Howard Hughes Medical Institute (HHMI) Research Training Fellowship
Publications & Presentations
PubMed
- Artificial intelligence enhances screening efficiency for inflammatory bowel disease clinical trials: a prospective study.Akshita Gupta, Ryan C Ungaro, Adam Steinlauf, Jean-Frederic Colombel, Sari Feldman
Inflammatory Bowel Diseases. 2026-08-01 - Tryptophan pathway metabotypes associate with disease activity and immune-metabolic dysfunction in inflammatory bowel disease.Danielle M M Harris, Arno R Bourgonje, Peder Rustøen Braadland, Cathy McShane, Lina Welz
Medrxiv. 2026-05-04 - Integrated long-term safety of 10-year ozanimod treatment: results from clinical trials in patients with moderate-to-severe ulcerative colitis or relapsing multiple sc...David T Rubin, Silvio Danese, Hiroshi Nakase, Ryan C Ungaro, Douglas C Wolf
Inflammatory Bowel Diseases. 2026-05-01
Journal Articles
- Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel DiseasesRyan Ungaro, Daniel J Stein, Andres J Yarur, Amir Patel, Marla Dubinsky, Digestive Diseases and Sciences
Press Mentions
Integrating Brain-Gut Behavior Therapy in Crohn’s CareSeptember 16th, 2025- HMN 2025: What Are the Unique Biological Markers in Sufferers with Gentle Crohn’s IllnessJuly 22nd, 2025
- Blood-Based Test May Predict Crohn’s Disease 2 Years Before OnsetMay 21st, 2025
Grant Support
- Blood Protein Markers of Biologic Treatment Response in Crohn's DiseaseICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2023–2025
Professional Memberships
- Member
- Member
- Member
- Crohn's and Colitis Foundation of AmericaMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
